Clotic (clotrimazole) Otic Solution Liquid
NDC Package 15370-220-99
Package Information
Clotic (clotrimazole) Otic Solution (clotrimazole) liquids is a medication used to treat vaginal yeast infections. This formulation utilizes a liquid delivery system. Marketed by Carwin Pharmaceutical Associates, Llc, this product is identified by NDC 15370-220 and is authorized under FDA application NDA217628.
Identification & Billing
- RxCUI: 2725165 - clotrimazole 1 % Otic Solution
- RxCUI: 2725165 - clotrimazole 10 MG/ML Otic Solution
- RxCUI: 2725626 - Clotic 1 % Otic Solution
- RxCUI: 2725626 - clotrimazole 10 MG/ML Otic Solution [Clotic]
- RxCUI: 2725626 - Clotic 10 MG/ML Otic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 15370 - Carwin Pharmaceutical Associates, Llc
- 15370-220 - Clotic (clotrimazole) Otic Solution
- 15370-220-99 - 1 POUCH in 1 CARTON / 2 VIAL, SINGLE-DOSE in 1 POUCH / .17 mL in 1 VIAL, SINGLE-DOSE
- 15370-220 - Clotic (clotrimazole) Otic Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (15370-220). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 15370-220-99 identifies a specific commercial package of 1 pouch in 1 carton / 2 vial, single-dose in 1 pouch / .17 ml in 1 vial, single-dose of Clotic (clotrimazole) Otic Solution, a human prescription drug labeled by Carwin Pharmaceutical Associates, Llc. This liquid is formulated for auricular (otic) use and contains clotrimazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carwin Pharmaceutical Associates, Llc on February 19, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat vaginal yeast infections. Clotrimazole reduces vaginal burning, itching, and discharge that may occur with this condition. This medication is an azole antifungal. It works by stopping the growth of yeast (fungus) that causes the infection. The vaginal product comes in 2 forms (a vaginal cream or tablet). Some products come with a skin cream to be applied to the area around the outside of the vagina. Ask your doctor before using this medication for self-treatment if this is your first vaginal infection. This medication only works for vaginal fungal infections. You may have a different type of infection (such as bacterial vaginosis) and may need a different medication. If you have fever, chills, flu-like symptoms, stomach/abdominal pain, or a bad-smelling vaginal discharge, do not use this medication. Contact your doctor right away because these may be signs of a more serious infection.
How is this Carwin Pharmaceutical Associates, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 15370022099. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.